Meet the speaker #7 | Perturb 2027

Leader of a group at Biohub in San Francisco, Dr. Leonetti’s team uses proteomics, AI/ML, functional genomics and proteomics to uncover protein localization and interaction in human cells. Learn more about his research.

Manuel Leonetti from Chan Zuckerberg Biohub, speaker for Perturb 2027

Manuel Leonetti

Manu Leonetti is the Senior Director of Systems Biology at Biohub San Francisco, where he leads interdisciplinary efforts to understand, predict, and ultimately control cellular behavior. His research combines functional genomics, quantitative imaging, proteomics, and AI/ML to map cellular organization and uncover the molecular rules governing cell-state transitions. His team developed proteome-scale maps of protein localization and interactions in human cells such as OpenCell (opencell.czbiohub.org) and Organelle IP (organelles.czbiohub.org). Their current work integrates live-cell imaging, multi-modal perturbation screening, and predictive modeling to learn the rules by which cells transition between states, and ultimately to make those transitions programmable.

Less than one month left to enjoy the early bird ticket pricing and submit abstracts. Information available at:

More news

Meet the speaker #6 | Perturb 2027

Professor at UCSF and a Core Investigator at the Arc Institute, get to know more about Dr. Gilbert, an early pioneer in repurposed CRISPR systems that are used to turn genes on and off (CRISPRa/i and CRISPRoff/on).

Meet the speaker #5 | Perturb 2027

Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, get to know more about Dr. Marson’s research with genetically modified T cells.

Myllia announces newly formed board with industry leaders

Single-cell commercial leader Simone Günther, US biotech veteran Sandy Zweifach, and Werner Lanthaler (Wlanholding) join to guide Myllia's next phase of growth